Liver, Pancreas, Esophagus, Gallbladder

Future of liver disease treatment. Xenotransplantation of liver. 14

Can fatty liver disease be reversed? NAFLD and NASH treatment. 4

How to improve health of your liver? Difficulty to keep low weight. 16

Genetic tests to find risks for liver disease [NAFLD and NASH]. 6

Liver cancer risk and fatty liver disease. Cancer screening in NASH, NAFLD. 10

Future in esophageal cancer treatment. Precision medicine. Tumor genome sequencing. 10

Coffee reduces risks of liver disease. Coffee and NAFLD prevention. 13

Esophageal carcinoma diagnosis. PET CT. Endoscopic ultrasound. Cure at early stage is possible. 5

Does GERD anti-reflux surgery reduce esophageal cancer risks? The risk does not go down to zero. 2

Non-obese patients with NAFLD [fatty liver disease]. ‘Lean NASH’. 2

Esophageal cancer treatment FAQ. Prognosis. When surgery is not beneficial? 11

Esophageal carcinoma radiotherapy. ‘East’ vs. ‘West’ differences in radiotherapy use. 7

Leading drug candidates for NASH therapy. NAFLD, fatty liver disease treatment. 12

What is Non-Alcoholic Fatty Liver Disease? NAFLD Diagnostic Criteria. 1

Dr. Jari Rasanen. Esophageal cancer and Lung cancer expert. Biography. 0

Gut microbiome and fatty liver disease. NAFLD, NASH, and Fecal transplantation. 7

GERD anti-reflux surgery often fails after 10 years. PPI medications and esophageal cancer risk. 3

Most patients with fatty liver disease & NASH do not have symptoms. Alcohol is often not to blame. 17

Food supplements and generic drugs for NASH and NAFLD. 8

How NASH differs from NAFLD. What drives progression to NASH? 5

Gastroesophageal reflux disease and esophageal cancer. 1

FAQ from patients with fatty liver disease. Life quality, prognosis, alcohol use. 15

Esophageal carcinoma. Minimally invasive surgery vs. classic surgery. Surgeon’s skill is paramount. 8

Hepatic Stellate Cells cause fatty liver disease. NAFLD and NASH causes. 9

Esophageal carcinoma risks and symptoms. ‘East’ vs. ‘West’ differences in esophageal cancer. 4

Dr. Scott L Friedman. Liver disease, NAFLD, NASH Expert. Biography. 0

Esophageal carcinoma. Neoadjuvant chemotherapy vs. upfront surgery. 6

When new drugs will be approved for fatty liver disease? 11

Diagnostic tests for fatty liver disease, NAFLD. FibroScan and MR Elastography. 3

Patient’s story. Metastatic esophageal cancer. Success of double neoadjuvant chemotherapy. 12

Cancer surgery failures and challenges. Ovarian cancer. Eminent cancer surgeon.

Hypertension in diabetes and in metabolic syndrome. Best treatment options. 2

Pancreatic cancer screening. Liver cancer screening. 10

MRI of liver. MRCP of pancreas. MRCP or ERCP? 9

Chemotherapy selection for metastatic peritoneal cancer. Precision medicine selection. 14

How to overcome skeptics in work and in life? Leading cancer surgeon explains. 9

Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7

Gallbladder cancer treatment options. 7

Best surgical treatment for liver cancer. Surgical technique from Japan. 5

Pancreatic cancer. Quality of life depends on local control of tumor. 4